Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma Ruchika Sharma19 Nov 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
JnJ gets USFDA nod for Rybrevant plus standard of care chemotherapy for lung cancer treatment Ruchika Sharma21 Sept 2024 4:00 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) in...
EMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer after failure of prior therapy Ruchika Sharma4 Aug 2024 11:00 AM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer Ruchika Sharma5 Jun 2024 2:00 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...
JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations Ruchika Sharma28 April 2024 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Zydus Lifesciences Chemotherapy drug Pemetrexed gets USFDA okay Ruchika Sharma26 May 2022 1:29 PM ISTThe drug will be manufactured at Zydus Hospira.
Aurobindo Pharma arm bags USFDA nod for Pemetrexed for Injection Ruchika Sharma26 May 2022 1:14 PM ISTPemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Sun Pharma cancer drug Pemetrexed Solution for Infusion gets CDSCO panel okay Medical Dialogues Team23 July 2021 6:23 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Zydus Cadila gets USFDA nod for Pemetrexed for Injection Ruchika Sharma26 Jun 2021 9:30 AM ISTAhmedabad: Drug major, Zydus Cadila, has recently announced that the company has received tentative approval from the United States Food &...
